As advances in science and medicine help us to live longer, VC investors are keen to bank startups in the healthtech space. But how are they doing it?
The prolonged hold times, which has increased to 6.17 years, are reflective of a dealmaking environment that’s becoming challenging, even though PE firms have oodles of capital.
By Tim Sheehan
Stay up to date with news and deals